214 related articles for article (PubMed ID: 1719467)
1. Nuclear localization is essential for the activity of p53 protein.
Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
[TBL] [Abstract][Full Text] [Related]
2. Modulation of transformation of primary epithelial cells by the second exon of the Ad5 E1A12S gene.
Douglas JL; Gopalakrishnan S; Quinlan MP
Oncogene; 1991 Nov; 6(11):2093-103. PubMed ID: 1945414
[TBL] [Abstract][Full Text] [Related]
3. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
4. The properties of p53 proteins selected for the loss of suppression of transformation.
Olson DC; Levine AJ
Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
[TBL] [Abstract][Full Text] [Related]
7. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
[TBL] [Abstract][Full Text] [Related]
8. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
Tarunina M; Grimaldi M; Ruaro E; Pavlenko M; Schneider C; Jenkins JR
Oncogene; 1996 Aug; 13(3):589-98. PubMed ID: 8760300
[TBL] [Abstract][Full Text] [Related]
9. Efficient nuclear localization of the Ad5 E1A 12S protein is necessary for immortalization but not cotransformation of primary epithelial cells.
Douglas JL; Quinlan MP
Cell Growth Differ; 1994 May; 5(5):475-83. PubMed ID: 8049154
[TBL] [Abstract][Full Text] [Related]
10. Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.
Shaulsky G; Goldfinger N; Rotter V
Cancer Res; 1991 Oct; 51(19):5232-7. PubMed ID: 1717142
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion.
Tuck SP; Crawford L
Oncogene Res; 1989; 4(2):81-96. PubMed ID: 2654816
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
Thomas M; Matlashewski G; Pim D; Banks L
Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
Yam JW; Zheng JY; Hsiao WL
Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
[TBL] [Abstract][Full Text] [Related]
14. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
Hansen RS; Braithwaite AW
Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
16. Involvement of wild-type p53 protein in the cell cycle requires nuclear localization.
Shaulsky G; Goldfinger N; Peled A; Rotter V
Cell Growth Differ; 1991 Dec; 2(12):661-7. PubMed ID: 1809377
[TBL] [Abstract][Full Text] [Related]
17. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
Schmieg FI; Simmons DT
Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the bipartite nuclear localization signal of protein LANA2 from Kaposi's sarcoma-associated herpesvirus.
Muñoz-Fontela C; Rodríguez E; Nombela C; Arroyo J; Rivas C
Biochem J; 2003 Sep; 374(Pt 2):545-50. PubMed ID: 12767255
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated ras genes.
Sharma S; Schwarte-Waldhoff I; Oberhuber H; Schäfer R
Cell Growth Differ; 1993 Oct; 4(10):861-9. PubMed ID: 8274455
[TBL] [Abstract][Full Text] [Related]
20. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
Aloni-Grinstein R; Zan-Bar I; Alboum I; Goldfinger N; Rotter V
Oncogene; 1993 Dec; 8(12):3297-305. PubMed ID: 8247532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]